Inventor · disambiguated record
Rebecca Newton
Also filed as: NEWTON REBECCA
6 granted patents·5 pending applications·13 citations·filing 2017–2024
78Inventor score
Files withCANCER RESEARCH TECH LTD11
Top patents by PatentIndex Score
11 records- 0192US11680068B2Compounds useful as RET inhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Granted Jun 20, 2023·1 cites·14 claims
- 0290US11352361B2Compounds useful as RET inhibitorsCANCER RESEARCH TECH LTD·Filed 2018·Granted Jun 7, 2022·3 cites·22 claims
- 0389US10954241B2Heterocyclic compounds as ret kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Mar 23, 2021·3 cites·29 claims
- 0488US10844067B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2017·Granted Nov 24, 2020·4 cites·27 claims
- 0587US11548896B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2021·Granted Jan 10, 2023·1 cites·30 claims
- 0685US11661423B2Heterocyclic compounds as RET kinase inhibitorsCANCER RESEARCH TECH LTD·Filed 2020·Granted May 30, 2023·1 cites·24 claims
- 0785US2025236624A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 0882US2025243202A1Compounds Useful as RET InhibitorsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 0981US2024132504A1Compounds Useful as RET InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
- 1078US2023339954A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2022·Application pending·0 cites
- 1176US2024116938A1Heterocyclic Compounds as RET Kinase InhibitorsCANCER RESEARCH TECH LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rebecca Newton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →